血塞通和尼莫地平治疗脑梗塞的药物经济学分析  

The pharmacoeconomic analysis of Xuesaitong and nimodipine in treatment of cerebral infarction

作　　者：查振中[1] 

机构地区：[1]安庆石化医院,安徽安庆246001

出　　处：《中国现代应用药学》2003年第6期523-524,共2页Chinese Journal of Modern Applied Pharmacy

摘　　要：目的　从药物经济学角度分析评价血塞通注射液和尼莫地平注射液治疗脑梗塞的特点。方法　运用成本 效果分析法 ,计算两种治疗方案 1个疗程的治疗费用和临床疗效 ,并计算成本 效果比 (C/E)。结果　血塞通组治疗费用为 1972 .4 0元 /疗程 ,有效率 91.84 % ;尼莫地平组治疗费用为 2 890 .4 0元 /疗程 ,有效率 90 .6 2 % ,两组的C/E分别为 2 1.4 6和 31.90。OBJECTIVE To analyze and evaluate the pharmacoeconomic characteristics of Xuesaitong injection and nimodipine injection in treatment of cerebral infarction. METHOD Cost effectiveness analysis method was used to calculate the cost of treatment and the clinic effectiveness of two therapeutic schemes in one period of treatment. The cost effectiveness ratio (C/E) was calculated at the same time. RESULTS The cost was 1972.40 RMB in Xuesaitong group , 2890.40 RMB in nimodipine group .The effective rates were 91.84% and 90.62% ,and the C/E were 21.64 and 31.90 respectively.CONCLUSION The xuesaitong group had advantage in C/E, and was one of better treatment schemes of cerebral infarction.

关 键 词：成本-效果分析法 血塞通 尼莫地平 脑梗塞 

分 类 号：R971[医药卫生—药品] R956[医药卫生—药学]